InvestorsHub Logo
Followers 49
Posts 2653
Boards Moderated 0
Alias Born 12/19/2015

Re: None

Tuesday, 12/12/2023 11:52:29 AM

Tuesday, December 12, 2023 11:52:29 AM

Post# of 692405
“One approach to DC-based vaccination is the use of autologous or patient-derived, which have shown promising clinical efficacy when pulsed with tumor lysates. In a phase III study (NCT00045968) for newly diagnosed GB, the vaccine DCVax-L showed great potential or this immunization approach when used in conjunction with standard treatment.”

https://www.researchgate.net/publication/376376475_Immunotherapy_Advancing_glioblastoma_treatment-A_narrative_review_of_scientific_studies
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News